Voyager Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Lexington, MA
VYGR chart
What traders are saying about $VYGR
Latest postsVoyager Therapeutics, Inc. news
- Voyager names Robin Swartz president. Voyager Therapeutics stock costs EUR 1.59
ad-hoc-news.de ·
- Voyager Therapeutics to present Alzheimer’s gen...
Pluang ·
- Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026
Yahoo Finance ·
- Voyager names Swartz president. USD 107.2 million values Voyager Therapeutics stock
ad-hoc-news.de ·
- CCORF Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $12
Moomoo ·
- Voyager Therapeutics, Inc. Estimates – NASDAQ:VYGR
TradingView ·
- Voyager Therapeutics (NasdaqGS:VYGR) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- Voyager Therapeutics CEO Al Sandrock to step down after Alzheimer's trial data
The Business Journals ·
- Voyager Therapeutics names Robin Swartz as president
Investing.com ·
- Voyager Therapeutics Names Robin Swartz President, Plans CEO Transition in 2027
citybiz ·
- Voyager Therapeutics appoints Robin Swartz as president, outlines CEO succession plan By Investing.com
Investing.com India ·
- Form 8K Voyager Therapeutics Inc For: 21 October By Investing.com
Investing.com India ·
Voyager Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $40.4M | $80.0M | $250.0M | $40.9M |
| Net income | -$119.7M | -$65.0M | $132.3M | -$46.4M |
| Diluted EPS | $-2.04 | $-1.13 | $2.97 | $-1.21 |
| Total assets (year end) | $252.3M | $393.1M | $351.3M | $159.4M |
| Cash and equivalents (year end) | $65.3M | $71.4M | $68.8M | $99.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Voyager Therapeutics, Inc.
- Ticker
- VYGR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Lexington, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1640266
Frequently asked questions
What exchange is Voyager Therapeutics, Inc. listed on?
Voyager Therapeutics, Inc. trades on the Nasdaq under the ticker symbol VYGR.
What industry is Voyager Therapeutics, Inc. in?
Voyager Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Voyager Therapeutics, Inc. headquartered?
Voyager Therapeutics, Inc.'s business address on file with the SEC is in Lexington, MA.
When does Voyager Therapeutics, Inc.'s fiscal year end?
Voyager Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Voyager Therapeutics, Inc. report?
Voyager Therapeutics, Inc. reported $40.4M in revenue for calendar year 2025, according to its SEC filings.